INTRAARTERIAL CHEMOTHERAPY OF HEAD AND NECK TUMORS
- 1 March 1986
- journal article
- research article
- Vol. 7 (2) , 343-348
Abstract
Forty-one patients with advanced recurrent or untreated head and neck tumors were treated with intraarterial short-term (1-1 1/2 hr) infusion of cisplatin into the external carotid artery, achieving an immediate tumor response rate of 29.3%. Tumor extent within or beyond the territory of a single external carotid artery was the only significant factor identified affecting the tumor response rate (57.1% vs. 14.8%). Treatment with intraarterial chemotherapy using superselective catheterization before irradiation or surgery is beneficial in some patients.This publication has 7 references indexed in Scilit:
- Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumorsCancer, 1984
- Clinical pharmacokinetics of intraarterial cisplatin in humans.Journal of Clinical Oncology, 1983
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- QUENCHING OF DNA - PLATINUM(II) MONOADDUCTS AS A POSSIBLE MECHANISM OF RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II) IN L1210-CELLS1983
- Intra-arterial Cisplatin Treatment of Adenoid Cystic CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1982
- Phase I-II trial of percutaneous intra-arterial Cis-diamminedichloro platinum (II) for regionally confined malignancyCancer, 1980
- Continuous arterial infusion of head and neck tumors.Improvements in technique by retrograde temporal artery catheterizationCancer, 1963